Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.

Saxena A, Chua TC, Bester L, Kokandi A, Morris DL.

Ann Surg. 2010 May;251(5):910-6. doi: 10.1097/SLA.0b013e3181d3d24a.

PMID:
20395859
2.

A systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.

Jia Z, Jiang G, Zhu C, Wang K, Li S, Qin X.

Eur J Radiol. 2017 Jul;92:111-115. doi: 10.1016/j.ejrad.2017.05.005. Epub 2017 May 4. Review.

PMID:
28624008
3.

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

Saxena A, Bester L, Shan L, Perera M, Gibbs P, Meteling B, Morris DL.

J Cancer Res Clin Oncol. 2014 Apr;140(4):537-47. doi: 10.1007/s00432-013-1564-4. Epub 2013 Dec 7. Review.

PMID:
24318568
4.

Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.

Kennedy A, Coldwell D, Sangro B, Wasan H, Salem R.

Am J Clin Oncol. 2012 Feb;35(1):81-90. doi: 10.1097/COC.0b013e3181ec60b8. Review.

PMID:
20938320
5.

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.

Al-Adra DP, Gill RS, Axford SJ, Shi X, Kneteman N, Liau SS.

Eur J Surg Oncol. 2015 Jan;41(1):120-7. doi: 10.1016/j.ejso.2014.09.007. Epub 2014 Oct 7. Review.

6.

Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival.

Swinburne NC, Biederman DM, Besa C, Tabori NE, Fischman AM, Patel RS, Nowakowski FS, Gunasekaran G, Schwartz ME, Lookstein RA, Kim E.

Cancer Biother Radiopharm. 2017 Jun;32(5):161-168. doi: 10.1089/cbr.2017.2189. Epub 2017 Jun 9. Review.

PMID:
28598685
7.

Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.

Jia Z, Wang W.

Eur J Radiol. 2018 Mar;100:23-29. doi: 10.1016/j.ejrad.2018.01.012. Epub 2018 Jan 9. Review.

PMID:
29496075
8.

Radioembolization of hepatic tumors.

Kennedy A.

J Gastrointest Oncol. 2014 Jun;5(3):178-89. doi: 10.3978/j.issn.2078-6891.2014.037. Review.

9.

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis.

Dendy MS, Ludwig JM, Kim HS.

Oncotarget. 2017 Jun 6;8(23):37912-37922. doi: 10.18632/oncotarget.16007. Review.

10.

Liver transplantation for unresectable pancreatic neuroendocrine tumors with liver metastases in an era of transplant oncology.

Shimata K, Sugawara Y, Hibi T.

Gland Surg. 2018 Feb;7(1):42-46. doi: 10.21037/gs.2017.12.11. Review.

Supplemental Content

Support Center